The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis

By Molyneux P.D.   Kappos L.   Polman C.   Pozzilli C.   Barkhof F.   Filippi M.   Yousry T.   Hahn D.   Wagner K.   Ghazi M.   Beckmann K.   Dahlke F.   Losseff N.   Barker G.J.   Thompson A.J.   Miller D.H.  

Brain, Vol. 123, Iss. 11, 2000-11 ,pp. : 2256-2263

Oxford University Press

Access to resources Recommend Favorite

Effect of natalizumab on conversion of gadolinium enhancing lesions to T1 hypointense lesions in relapsing multiple sclerosis

By Dalton Catherine   Miszkiel Katherine   Barker Gareth   MacManus David   Pepple Tracy   Panzara Michael   Yang Minhua   Hulme Allison   O’Connor Paul   Miller David  

Journal of Neurology, Vol. 251, Iss. 4, 2004-04 ,pp. : 407-413

Springer Publishing Company

Access to resources Recommend Favorite

Interferon beta in secondary progressive multiple sclerosis: Daily clinical practice

By Río J.   Tintoré M.   Nos C.   Téllez N.   Galán I.   Pelayo R.   Montalban X.  

Journal of Neurology, Vol. 254, Iss. 7, 2007-07 ,pp. : 849-853

Springer Publishing Company

Access to resources Recommend Favorite

Plasma ubiquitin-proteasome system profile in patients with multiple sclerosis: correlation with clinical features, neuroimaging, and treatment with interferon-beta-1b

By Minagar Alireza   Ma Wanlong   Zhang Xi   Wang Xiuqiang   Zhang Ke   Alexander J Steven   Gonzalez-Toledo Eduardo   Albitar Maher  

Neurological Research, Vol. 34, Iss. 6, 2012-07 ,pp. : 611-618

Maney Publishing

Access to resources Recommend Favorite

Psoriasis during interferon beta treatment for multiple sclerosis

By La Mantia Loredana   Capsoni F.  

Neurological Sciences, Vol. 31, Iss. 3, 2010-06 ,pp. : 337-339

Springer Publishing Company

Access to resources Recommend Favorite